BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17932585)

  • 1. The 'valvulo-metabolic' risk in calcific aortic valve disease.
    Mathieu P; Després JP; Pibarot P
    Can J Cardiol; 2007 Oct; 23 Suppl B(Suppl B):32B-39B. PubMed ID: 17932585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osseous and chondromatous metaplasia in calcific aortic valve stenosis.
    Torre M; Hwang DH; Padera RF; Mitchell RN; VanderLaan PA
    Cardiovasc Pathol; 2016; 25(1):18-24. PubMed ID: 26386747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcific aortic valve disease should not be considered as a degenerative disease anymore.
    Li YB; Hu CL; Liu J; Tang QZ; Huang CX
    Med Hypotheses; 2007; 68(6):1233-5. PubMed ID: 17011715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural Pathology of Atherosclerosis, Calcific Aortic Valve Disease, and Bioprosthetic Heart Valve Degeneration: Commonalities and Differences.
    Kostyunin A; Mukhamadiyarov R; Glushkova T; Bogdanov L; Shishkova D; Osyaev N; Ovcharenko E; Kutikhin A
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical characterization of natural and bioprosthetic heart valve calcific deposits: implications for prevention.
    Tomazic BB; Edwards WD; Schoen FJ
    Ann Thorac Surg; 1995 Aug; 60(2 Suppl):S322-7. PubMed ID: 7646181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies.
    Freeman RV; Otto CM
    Circulation; 2005 Jun; 111(24):3316-26. PubMed ID: 15967862
    [No Abstract]   [Full Text] [Related]  

  • 7. Early postoperative bioprosthetic valve calcification.
    Iyer A; Malik P; Prabha R; Kugathasan G; Kuteyi O; Marney L; Larbalestier R
    Heart Lung Circ; 2013 Oct; 22(10):873-4. PubMed ID: 23380041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early calcific stenosis of aortic and mitral Ionescu-Shiley valves in a patient with bioprosthetic infection.
    Williams EH; Gonti VR; Nishimura A; Stout LC; Ferrans V
    J Thorac Cardiovasc Surg; 1981 Sep; 82(3):391-7. PubMed ID: 7278328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it time for a new paradigm in calcific aortic valve disease?
    Owens DS; Otto CM
    JACC Cardiovasc Imaging; 2009 Aug; 2(8):928-30. PubMed ID: 19679279
    [No Abstract]   [Full Text] [Related]  

  • 10. Is degenerative calcification of the native aortic valve similar to calcification of bioprosthetic heart valves?
    David TE; Ivanov J
    J Thorac Cardiovasc Surg; 2003 Oct; 126(4):939-41. PubMed ID: 14566227
    [No Abstract]   [Full Text] [Related]  

  • 11. Demographic characteristics of patients undergoing aortic valve replacement for stenosis: relation to valve morphology.
    Davies MJ; Treasure T; Parker DJ
    Heart; 1996 Feb; 75(2):174-8. PubMed ID: 8673757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cronic non-rheumatic valvular heart disease. An autopsy study.
    Hallgrímsson J
    Acta Pathol Microbiol Scand A; 1976 May; 84(3):247-52. PubMed ID: 1274589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The degeneration of biological cardiovascular prostheses under pro-calcific metabolic conditions in a small animal model.
    Assmann A; Zwirnmann K; Heidelberg F; Schiffer F; Horstkötter K; Munakata H; Gremse F; Barth M; Lichtenberg A; Akhyari P
    Biomaterials; 2014 Aug; 35(26):7416-28. PubMed ID: 24917029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study.
    Novaro GM; Katz R; Aviles RJ; Gottdiener JS; Cushman M; Psaty BM; Otto CM; Griffin BP
    J Am Coll Cardiol; 2007 Nov; 50(20):1992-8. PubMed ID: 17996566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible early recoil phenomenon in a self-expandable transcatheter bioprosthesis compressed by a huge annular calcification.
    Kobayashi T; Yamamoto M; Tsujimoto S
    Eur Heart J; 2018 Jul; 39(28):2690. PubMed ID: 29554226
    [No Abstract]   [Full Text] [Related]  

  • 16. Extracellular Matrix in Calcific Aortic Valve Disease: Architecture, Dynamic and Perspectives.
    Di Vito A; Donato A; Presta I; Mancuso T; Brunetti FS; Mastroroberto P; Amorosi A; Malara N; Donato G
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease.
    Cho KI; Sakuma I; Sohn IS; Jo SH; Koh KK
    Atherosclerosis; 2018 Oct; 277():60-65. PubMed ID: 30173080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement.
    Yeghiazaryan K; Skowasch D; Bauriedel G; Schild H; Golubnitschaja O
    Amino Acids; 2007 Jan; 32(1):109-14. PubMed ID: 16874466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of Osteogenic Regulation in Calcific Porcine Aortic Valves.
    Lu F; Wu H; Bai Y; Gong D; Xia C; Li Q; Lu F; Xu Z
    Heart Surg Forum; 2018 Sep; 21(5):E375-E381. PubMed ID: 30311888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-138 Suppresses Osteoblastic Differentiation of Valvular Interstitial Cells in Degenerative Calcific Aortic Valve Disease.
    Lu P; Yin B; Liu L
    Int Heart J; 2019 Jan; 60(1):136-144. PubMed ID: 30464116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.